What is an aromatase inhibitor (AI)?
An aromatase inhibitor is a medication that blocks the enzyme aromatase, which converts testosterone to estrogen, used during testosterone replacement therapy to manage estrogen-related side effects.
Aromatase inhibitors are drugs that block the enzyme responsible for converting testosterone into estrogen. During testosterone replacement therapy, the body's increased testosterone levels can trigger unwanted estrogen conversion, leading to side effects like gynecomastia (breast tissue growth), water retention, and mood changes. AIs like anastrozole, letrozole, and exemestane work by suppressing this conversion process, allowing testosterone to remain bioavailable rather than being metabolized into estrogen.
In the context of TRT, aromatase inhibitors serve a specific purpose: they help maintain an optimal estrogen-to-testosterone ratio. Many men undergoing testosterone therapy find that their natural estrogen regulation is disrupted by elevated testosterone levels, making pharmacological control necessary. Rather than allowing estrogen to accumulate unchecked, an AI can be taken at a lower dose alongside testosterone to keep estrogen levels within a normal range.
Whether an individual needs an AI during testosterone replacement therapy depends on factors including baseline estrogen sensitivity, the dose and type of testosterone prescribed, and individual metabolic response. Not all men on TRT require an AI, but for those who do develop estrogen-related symptoms, adding one can significantly improve treatment outcomes and reduce side effects.